Zubin Bhagwagar

• Deepak Cyril Dsouza
• Gerard Sanacora
• Gilles Tamagnan
• Godfrey Pearlson
• Hilary Blumberg
• Irina Esterlis
• John Krystal
• Kelly Cosgrove
• Marvin M Chun
• Naomi Driesen
• Robert Beech
• Sheila Umlauf

Affective Disorders, Psychotic; Magnetic Resonance Imaging; Neurobiology; Neurosciences; Magnetic Resonance Spectroscopy; Psychiatry; Psychopharmacology; Neuropsychiatry; Neuroimaging

• An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept studyGeisen C, Kjaer M, Fleck E, Skogen B, Armstrong R, Behrens F, Bhagwagar Z, Braeuninger S, Mortberg A, Olsen K, Gastón Schäfer S, Walter C, Seifried E, Wikman A, Kjeldsen-Kragh J, Koehm M. An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study. Journal Of Thrombosis And Haemostasis 2022, 21: 838-849. PMID: 36696185, DOI: 10.1016/j.jtha.2022.11.041.
• Lithium for acute maniaBhagwagar Z, Goodwin G, Geddes J. Lithium for acute mania. Cochrane Database Of Systematic Reviews 2019, 2019 PMCID: PMC6524414, DOI: 10.1002/14651858.cd004048.pub3.
• P2‐422: vMRI and hippocampal volume in patients with suspected predementia Alzheimer's diseaseBudd D, Nalysnyk L, Fahrbach K, Bhagwagar Z, Berman R, Burns L, l'Italien G. P2‐422: vMRI and hippocampal volume in patients with suspected predementia Alzheimer's disease. Alzheimer's & Dementia 2012, 8: p411-p411. DOI: 10.1016/j.jalz.2012.05.2047.
• P2‐423: vMRI and whole‐brain volume in patients with mild‐to‐moderate Alzheimer's diseaseBudd D, Nalysnyk L, Fahrbach K, Bhagwagar Z, Berman R, Burns L, l'Italien G. P2‐423: vMRI and whole‐brain volume in patients with mild‐to‐moderate Alzheimer's disease. Alzheimer's & Dementia 2012, 8: p411-p412. DOI: 10.1016/j.jalz.2012.05.2048.
• P2‐412: A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild‐to‐moderate Alzheimer's diseaseBurns L, Rueckert D, Bhagwagar Z, Donohue M, Wolz R, Tiller J, Soares H, l'Italien G, Coric V, Hayes W, Fox N, Berman R. P2‐412: A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild‐to‐moderate Alzheimer's disease. Alzheimer's & Dementia 2012, 8: p408-p408. DOI: 10.1016/j.jalz.2012.05.2037.
• AntidepressantsBhagwagar Z, Heninger G. Antidepressants. 2012, 1185-1198. DOI: 10.1093/med/9780199696758.003.0153.
• Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distractersKerestes R, Ladouceur CD, Meda S, Nathan PJ, Blumberg HP, Maloney K, Ruf B, Saricicek A, Pearlson GD, Bhagwagar Z, Phillips ML. Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distracters. Psychological Medicine 2011, 42: 29-40. PMID: 21733287, DOI: 10.1017/s0033291711001097.
• Increased peripheral blood expression of electron transport chain genes in bipolar depressionBeech RD, Lowthert L, Leffert JJ, Mason PN, Taylor MM, Umlauf S, Lin A, Lee JY, Maloney K, Muralidharan A, Lorberg B, Zhao H, Newton SS, Mane S, Epperson CN, Sinha R, Blumberg H, Bhagwagar Z. Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disorders 2010, 12: 813-824. PMID: 21176028, PMCID: PMC3076072, DOI: 10.1111/j.1399-5618.2010.00882.x.
• Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.Saricicek A, Maloney K, Muralidharan A, Ruf B, Blumberg HP, Sanacora G, Lorberg B, Pittman B, Bhagwagar Z. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial. The Journal Of Clinical Psychiatry 2010, 72: 744-50. PMID: 21034692, DOI: 10.4088/jcp.09m05659gre.
• The Relationship Between Mood, Stress, and Tobacco SmokingWalderhaug E, Cosgrove K, Bhagwagar Z, Neumeister A. The Relationship Between Mood, Stress, and Tobacco Smoking. 2010, 147-161. DOI: 10.1007/978-1-4419-6373-4_10.
• Neurotransmitter Systems in Bipolar DisorderNakic M, Krystal J, Bhagwagar Z. Neurotransmitter Systems in Bipolar Disorder. 2010, 210-227. DOI: 10.1002/9780470661277.ch16.
• Association between serotonin transporter binding, physiological and environmental factors in healthy male subjectsComley R, Miller S, Murthy V, Bhagwagar Z, Turner D, Peers P, Riedel W, Grasby P, Rabiner E. Association between serotonin transporter binding, physiological and environmental factors in healthy male subjects. NeuroImage 2010, 52: s93-s94. DOI: 10.1016/j.neuroimage.2010.04.075.
• Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic RegionTaylor MJ, Sen S, Bhagwagar Z. Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region. Biological Psychiatry 2010, 68: 536-543. PMID: 20615496, PMCID: PMC2929304, DOI: 10.1016/j.biopsych.2010.04.034.
• P1‐387: Mild to moderate Alzheimer's disease (AD) clinical trials: The role of hippocampal atrophy as an inclusion criterionRisinger R, Berman R, Coric V, Han J, Kaplita S, Burns L, Bhagwagar Z, Hill D, Wolz R, Rueckert D, Feldman H. P1‐387: Mild to moderate Alzheimer's disease (AD) clinical trials: The role of hippocampal atrophy as an inclusion criterion. Alzheimer's & Dementia 2010, 6: s285-s286. DOI: 10.1016/j.jalz.2010.05.941.
• Diminished center-surround inhibition in patients with a history of depressionGolomb J, Ruf B, Beck J, Saricicek A, Hu J, Chun M, Bhagwagar Z. Diminished center-surround inhibition in patients with a history of depression. Journal Of Vision 2010, 8: 1029-1029. DOI: 10.1167/8.6.1029.
• P.1.025 Molecular imaging of beta-2 subunit containing nicotinic acetylcholine receptors in major depressive disorderSaricicek A, Esterlis I, Ruf B, Maloney K, Muralidharan A, Seibyl J, Tamagnan G, Bois F, Staley J, Bhagwagar Z. P.1.025 Molecular imaging of beta-2 subunit containing nicotinic acetylcholine receptors in major depressive disorder. European Neuropsychopharmacology 2010, 20: s22. DOI: 10.1016/s0924-977x(10)70027-4.
• P.2.e.029 Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo controlled trialSaricicek A, Maloney K, Lorberg B, Muralidharan A, Ruf B, Blumberg H, Hu J, Pittman B, Sanacora G, Bhagwagar Z. P.2.e.029 Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo controlled trial. European Neuropsychopharmacology 2009, 19: s465. DOI: 10.1016/s0924-977x(09)70728-x.
• Enhanced Visual Motion Perception in Major Depressive DisorderGolomb JD, McDavitt JR, Ruf BM, Chen JI, Saricicek A, Maloney KH, Hu J, Chun MM, Bhagwagar Z. Enhanced Visual Motion Perception in Major Depressive Disorder. Journal Of Neuroscience 2009, 29: 9072-9077. PMID: 19605644, PMCID: PMC2772577, DOI: 10.1523/jneurosci.1003-09.2009.
• NMDA Receptor Antagonist Ketamine Produces Opposing Effects on Resting and Task-Related Brain Activation During Working Memory in HumansDriesen N, McCarthy G, Bhagwagar Z, Calhoun V, D'Souza D, Holub J, Morgan P, Krystal J. NMDA Receptor Antagonist Ketamine Produces Opposing Effects on Resting and Task-Related Brain Activation During Working Memory in Humans. NeuroImage 2009, 47: s145. DOI: 10.1016/s1053-8119(09)71458-2.
• A Novel Paradigm for Examining the Interfering Effects of Emotional Distracters During a Working Memory Task: A Functional Magnetic Resonance Imaging (fMRI) StudyKerestes R, Ladouceur C, Meda S, Blumberg H, Nathan P, Maloney K, Ruf B, Saricicek A, Hu J, Pearlson G, Bhagwagar Z, Phillips M. A Novel Paradigm for Examining the Interfering Effects of Emotional Distracters During a Working Memory Task: A Functional Magnetic Resonance Imaging (fMRI) Study. NeuroImage 2009, 47: s191. DOI: 10.1016/s1053-8119(09)72145-7.
• Drs. Ghaznavi and Bhagwagar ReplyGHAZNAVI S, BHAGWAGAR Z. Drs. Ghaznavi and Bhagwagar Reply. American Journal Of Psychiatry 2008, 165: 1611-1612. DOI: 10.1176/appi.ajp.2008.08071105r.
• Nicotinic receptor dysfunction in major depressive disorder: A trait vulnerability marker of depressionBhagwagar Z, Esterlis I, Ruf B, Muralidharan A, Lorberg B, Saricicek A, Bois F, Tamagnan G, Seibyl J, Staley J. Nicotinic receptor dysfunction in major depressive disorder: A trait vulnerability marker of depression. NeuroImage 2008, 41: t176. DOI: 10.1016/j.neuroimage.2008.04.143.
• Lower brain serotonin transporter binding potential in unipolar acutely depressed patients — A preliminary [11C]DASB PET studySelvaraj S, Murthy V, Bhagwagar Z, Bose S, Cowen P, Grasby P. Lower brain serotonin transporter binding potential in unipolar acutely depressed patients — A preliminary [11C]DASB PET study. NeuroImage 2008, 41: t167. DOI: 10.1016/j.neuroimage.2008.04.134.
• Bipolar disorder: the neglected psychosisBhagwagar Z, Goodwin G. Bipolar disorder: the neglected psychosis. Psychiatry 2007, 6: 389-392. DOI: 10.1016/j.mppsy.2007.06.005.
• Lithium for acute maniaBhagwagar Z, Goodwin G, Geddes J. Lithium for acute mania. 2007 DOI: 10.1002/14651858.cd004048.pub2.
• Lithium for bipolar depressionBhagwagar Z, Goodwin G, Geddes J. Lithium for bipolar depression. 2007 DOI: 10.1002/14651858.cd004042.pub2.
• Changes of [11C]DASB binding in human brain after citalopram infusionHinz R, Murthy V, Selvaraj S, Taylor M, Cowen P, Bhagwagar Z, Grasby P. Changes of [11C]DASB binding in human brain after citalopram infusion. NeuroImage 2006, 31: t26. DOI: 10.1016/j.neuroimage.2006.04.016.
• 5-HT1A receptor density and defensive personality - interaction of neurochemistry, personality and depression explored with [11C]WAY 100635 PETRabiner E, Lawrence A, Bhagwagar Z, Murthy N, Bantick R, Cowen P, Grasby P. 5-HT1A receptor density and defensive personality - interaction of neurochemistry, personality and depression explored with [11C]WAY 100635 PET. Cerebrovascular And Brain Metabolism Reviews 2005, 25: s376-s376. DOI: 10.1038/sj.jcbfm.9591524.0376.
• Lamotrigine in the treatment of bipolar disorderBhagwagar Z, Goodwin G. Lamotrigine in the treatment of bipolar disorder. Expert Opinion On Pharmacotherapy 2005, 6: 1401-1408. PMID: 16013989, DOI: 10.1517/14656566.6.8.1401.
• Increased salivary cortisol after waking in depressionBhagwagar Z, Hafizi S, Cowen P. Increased salivary cortisol after waking in depression. Psychopharmacology 2005, 182: 54-57. PMID: 15991000, DOI: 10.1007/s00213-005-0062-z.
• P.2.01 The effects of altering dietary L-tryptophan on the performance of an iterated Prisoner's Dilemma (PD) game in healthy volunteersWood R, Rilling J, Sanfey A, Bhagwagar Z, Rogers R. P.2.01 The effects of altering dietary L-tryptophan on the performance of an iterated Prisoner's Dilemma (PD) game in healthy volunteers. European Neuropsychopharmacology 2005, 15: s32. DOI: 10.1016/s0924-977x(05)80141-5.
• Bipolar disorder: the neglected psychosisBhagwagar Z, Goodwin G. Bipolar disorder: the neglected psychosis. Psychiatry 2004, 3: 67-70. DOI: 10.1383/psyt.3.10.67.52406.
• P.1.028 Persistent reduction in brain 5-HT1A receptorbinding in recovered depressed men using positron emission tomography and [11C]WAY-100835Bhagwagar Z, Rabiner E, Sargente R, Grasby P, Cowen P. P.1.028 Persistent reduction in brain 5-HT1A receptorbinding in recovered depressed men using positron emission tomography and [11C]WAY-100835. European Neuropsychopharmacology 2004, 14: s185. DOI: 10.1016/s0924-977x(04)80117-2.
• Preferential 5-HT1A Autoreceptor Occupancy by Pindolol is Attenuated in Depressed Patients: Effect of Treatment or an Endophenotype of Depression?Rabiner E, Bhagwagar Z, Gunn R, Cowen P, Grasby P. Preferential 5-HT1A Autoreceptor Occupancy by Pindolol is Attenuated in Depressed Patients: Effect of Treatment or an Endophenotype of Depression? Neuropsychopharmacology 2004, 29: 1688-1698. PMID: 15127080, DOI: 10.1038/sj.npp.1300472.
• Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635Bhagwagar Z, Rabiner E, Sargent P, Grasby P, Cowen P. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Molecular Psychiatry 2004, 9: 386-392. PMID: 15042104, DOI: 10.1038/sj.mp.4001401.
• Increased Brain GABA Concentrations Following Acute Administration of a Selective Serotonin Reuptake InhibitorBhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews P, Cowen P. Increased Brain GABA Concentrations Following Acute Administration of a Selective Serotonin Reuptake Inhibitor. American Journal Of Psychiatry 2004, 161: 368-370. PMID: 14754790, DOI: 10.1176/appi.ajp.161.2.368.
• Inositol for depressive disordersTaylor M, Wilder H, Bhagwagar Z, Geddes J. Inositol for depressive disorders. Cochrane Database Of Systematic Reviews 2004, 2004: cd004049. PMID: 15106232, PMCID: PMC6984679, DOI: 10.1002/14651858.cd004049.pub2.
• Effects of beta-adrenoceptor blockade on components of human decision-makingRogers R, Lancaster M, Wakeley J, Bhagwagar Z. Effects of beta-adrenoceptor blockade on components of human decision-making. Psychopharmacology 2004, 172: 157-164. PMID: 14716472, DOI: 10.1007/s00213-003-1641-5.
• Normalization of Enhanced Fear Recognition by Acute SSRI Treatment in Subjects With a Previous History of DepressionBhagwagar Z, Cowen P, Goodwin G, Harmer C. Normalization of Enhanced Fear Recognition by Acute SSRI Treatment in Subjects With a Previous History of Depression. American Journal Of Psychiatry 2004, 161: 166-168. PMID: 14702268, DOI: 10.1176/appi.ajp.161.1.166.
• Bipolar-spectrum disorders: an epidemic unseen, invisible or unreal?Bhagwagar Z, Goodwin G. Bipolar-spectrum disorders: an epidemic unseen, invisible or unreal? Advances In Psychiatric Treatment 2004, 10: 1-3. DOI: 10.1192/apt.10.1.1.
• Lack of effect of a single dose of hydrocortisone on serotonin1A receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635Bhagwagar Z, Montgomery A, Grasby P, Cowen P. Lack of effect of a single dose of hydrocortisone on serotonin1A receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635. Biological Psychiatry 2003, 54: 890-895. PMID: 14573316, DOI: 10.1016/s0006-3223(03)00466-9.
• Increase in Concentration of Waking Salivary Cortisol in Recovered Patients With DepressionBhagwagar Z, Hafizi S, Cowen P. Increase in Concentration of Waking Salivary Cortisol in Recovered Patients With Depression. American Journal Of Psychiatry 2003, 160: 1890-1891. PMID: 14514508, DOI: 10.1176/appi.ajp.160.10.1890.
• GABA and mood disordersTAYLOR M, BHAGWAGAR Z, COWEN P, SHARP T. GABA and mood disorders. Psychological Medicine 2003, 33: 387-393. PMID: 12701660, DOI: 10.1017/s0033291702006876.
• Contrasting effects of citalopram and reboxetine on waking salivary cortisolHarmer C, Bhagwagar Z, Shelley N, Cowen P. Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology 2003, 167: 112-114. PMID: 12605289, DOI: 10.1007/s00213-003-1417-y.
• Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.Sharpley A, Bhagwagar Z, Hafizi S, Whale W, Gijsman H, Cowen P. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. The Journal Of Clinical Psychiatry 2003, 64: 192-6. PMID: 12633128, DOI: 10.4088/jcp.v64n0212.
• Lithium for bipolar depressionBhagwagar Z, Goodwin G, Geddes J. Lithium for bipolar depression. 2003 DOI: 10.1002/14651858.cd004042.
• Lithium for acute maniaBhagwagar Z, Goodwin G, Geddes J. Lithium for acute mania. 2003 DOI: 10.1002/14651858.cd004048.
• Acute SSRI Administration Affects the Processing of Social Cues in Healthy VolunteersHarmer C, Bhagwagar Z, Perrett D, Völlm B, Cowen P, Goodwin G. Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers. Neuropsychopharmacology 2003, 28: 148-152. PMID: 12496951, DOI: 10.1038/sj.npp.1300004.
• The role of lithium in the treatment of bipolar depressionBhagwagar Z, Goodwin G. The role of lithium in the treatment of bipolar depression. Clinical Neuroscience Research 2002, 2: 222-227. DOI: 10.1016/s1566-2772(02)00046-4.
• Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patientsBhagwagar Z, Hafizi S, Cowen P. Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients. Journal Of Affective Disorders 2002, 72: 249-255. PMID: 12450642, DOI: 10.1016/s0165-0327(01)00467-0.
• Inositol for depressive disordersTaylor M, Wilder H, Bhagwagar Z, Geddes J. Inositol for depressive disorders. 2002 DOI: 10.1002/14651858.cd004049.
• PET Measurement of the Influence of Corticosteroids on Serotonin-1A Receptor NumberMontgomery A, Bench C, Young A, Hammers A, Bhagwagar Z, Grasby P. PET Measurement of the Influence of Corticosteroids on Serotonin-1A Receptor Number. Clinical Science 2002, 103: 64p-64p. DOI: 10.1042/cs103064pa.
• State and Trait Abnormalities in Serotonin Function in Major DepressionBhagwagar Z, Whale R, Cowen P. State and Trait Abnormalities in Serotonin Function in Major Depression. Clinical Science 2002, 103: 65p-65p. DOI: 10.1042/cs103065p.
• Acute administration of citalopram facilitates memory consolidation in healthy volunteersHarmer C, Bhagwagar Z, Cowen P, Goodwin G. Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacology 2002, 163: 106-110. PMID: 12185407, DOI: 10.1007/s00213-002-1151-x.
• Acute citalopram administration produces correlated increases in plasma and salivary cortisolBhagwagar Z, Hafizi S, Cowen P. Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology 2002, 163: 118-120. PMID: 12185409, DOI: 10.1007/s00213-002-1149-4.
• Tryptophan Depletion Alters the Decision-Making of Healthy Volunteers through Altered Processing of Reward CuesRogers R, Tunbridge E, Bhagwagar Z, Drevets W, Sahakian B, Carter C. Tryptophan Depletion Alters the Decision-Making of Healthy Volunteers through Altered Processing of Reward Cues. Neuropsychopharmacology 2002, 28: 153-162. PMID: 12496952, DOI: 10.1038/sj.npp.1300001.
• Role of mood stabilizers in bipolar disorderBhagwagar Z, Goodwin G. Role of mood stabilizers in bipolar disorder. Expert Review Of Neurotherapeutics 2002, 2: 239-248. PMID: 19811005, DOI: 10.1586/14737175.2.2.239.
• State and trait abnormalities in serotonin function in major depressionBhagwagar Z, Whale R, Cowen P. State and trait abnormalities in serotonin function in major depression. The British Journal Of Psychiatry 2002, 180: 24-28. PMID: 11772847, DOI: 10.1192/bjp.180.1.24.
• Pindolol Augmentation of Selective Serotonin Reuptake Inhibitors: PET Evidence That the Dose Used in Clinical Trials Is Too LowRabiner E, Bhagwagar Z, Gunn R, Sargent P, Bench C, Cowen P, Grasby P. Pindolol Augmentation of Selective Serotonin Reuptake Inhibitors: PET Evidence That the Dose Used in Clinical Trials Is Too Low. American Journal Of Psychiatry 2001, 158: 2080-2082. PMID: 11729033, DOI: 10.1176/appi.ajp.158.12.2080.
• PET measurement of the influence of corticosteroids on serotonin-1A receptor numberMontgomery A, Bench C, Young A, Hammers A, Gunn R, Bhagwagar Z, Grasby P. PET measurement of the influence of corticosteroids on serotonin-1A receptor number. Biological Psychiatry 2001, 50: 668-676. PMID: 11704073, DOI: 10.1016/s0006-3223(01)01205-7.
• PET measurement of the influence of corticosteroids on serotonin-1A receptor numberMontgomery A, Bench C, Young A, Hammers A, Bhagwagar Z, Grasby P. PET measurement of the influence of corticosteroids on serotonin-1A receptor number. NeuroImage 2001, 13: 1075. DOI: 10.1016/s1053-8119(01)92404-8.
• Decreased sensitivity of 5-HT1D receptors in melancholic depressionWhale R, Clifford E, Bhagwagar Z, Cowen P. Decreased sensitivity of 5-HT1D receptors in melancholic depression. The British Journal Of Psychiatry 2001, 178: 454-457. PMID: 11331562, DOI: 10.1192/bjp.178.5.454.
• Modelling a loss event: effect of imagined bereavement on the hypothalamic–pituitary–adrenal axisMcCLEERY J, BHAGWAGAR Z, SMITH K, GOODWIN G, COWEN P. Modelling a loss event: effect of imagined bereavement on the hypothalamic–pituitary–adrenal axis. Psychological Medicine 2000, 30: 219-223. PMID: 10722192, DOI: 10.1017/s0033291799001361.
• Velo-cardio-facial (Shprintzen's) Syndrome, violence and schizophreniaBhagwagar Z, Mawson D. Velo-cardio-facial (Shprintzen's) Syndrome, violence and schizophrenia. Journal Of Forensic Psychiatry And Psychology 2000, 11: 449-455. DOI: 10.1080/09585180050142642.
• Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?Whale R, Bhagwagar Z, Cowen P. Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors? Psychopharmacology 1999, 145: 223-226. PMID: 10463324, DOI: 10.1007/s002130051052.
• Working with offenders: psychological practice in offender rehabilitation. Edited by Clive R. Hollin. Wiley, Chichester PO19 1UD, March 1996, 288 pp. ISBN 0‐471‐95776‐3. ISBN 0‐471‐95349‐0Bhagwagar Z. Working with offenders: psychological practice in offender rehabilitation. Edited by Clive R. Hollin. Wiley, Chichester PO19 1UD, March 1996, 288 pp. ISBN 0‐471‐95776‐3. ISBN 0‐471‐95349‐0. Criminal Behaviour And Mental Health 1998, 8: 323-324. DOI: 10.1002/cbm.271.
• Book Reviews : Fundamentals of Psychopharmacology— Second EditionBhagwagar Z. Book Reviews : Fundamentals of Psychopharmacology— Second Edition. Journal Of Psychopharmacology 1998, 12: 109-110. DOI: 10.1177/026988119801200118.
• Financial implications of Calman changes in psychiatryBhagwagar Z. Financial implications of Calman changes in psychiatry. BJPsych Bulletin 1997, 21: 784-785. DOI: 10.1192/pb.21.12.784-b.
• New terminology for ECT.Bhagwagar Z. New terminology for ECT. Australian & New Zealand Journal Of Psychiatry 1994, 28: 156-8. PMID: 8067964.